Sunpointe »

Atea Pharmaceuticals shares owned by Sunpointe

Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Sunpointe from 13F filings

Historical chart of Sunpointe investment in Atea Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Atea Pharmaceuticals held by Sunpointe consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atea Pharmaceuticals by Sunpointe

Quarter filed Position value Share count Share price at filing
2024-03-31 $48k 12k 4.04
2023-12-31 $36k 12k 3.05

More positions owned by Sunpointe

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Vaneck Etf Trust Mrngstr Wde Moat (MOAT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Short Treas Bd (SHV)
JPMorgan Chase & Co. (JPM)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
UnitedHealth (UNH)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Sunpointe

Top funds holding Atea Pharmaceuticals

EcoR1 Capital
BML Capital Management
Vanguard Group
Tang Capital Management
Federated Investors
Charles Schwab Investment Management
Jacobs Levy Equity Management
Newtyn Management
Banque Pictet & Cie Sa
Two Sigma Advisers
CM Management
Bank of America Corporation
Bank of New York Mellon
Goldman Sachs Group
Barclays

View all funds holding Atea Pharmaceuticals